Astorg strikes $1bn-plus deal for Thermo Fisher microbiology business
TOP STORY: Thermo Fisher Scientific has agreed to divest its microbiology division to private equity firm Astorg in a deal valued at approximately $1.08bn, according to a company statement. The transaction will be funded through a combination of cash proceeds and a $50m seller note.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.